Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
Heli Tolppanen(Inserm), Alexandre Mebazaa(Délégation Paris 5), José Silva‐Cardoso(Universidade do Porto), Lars Køber(Copenhagen University Hospital), Hölger Thiele(Leipzig Heart Institute), Kari Pulkki(University of Eastern Finland), Matias Greve Lindholm(Jisc), Jindřich Špinar(Masaryk University), Tuukka Tarvasmäki(University of Helsinki), Alessandro Sionís, Mattia Arrigo(University Hospital of Zurich), Veli‐Pekka Harjola(University of Helsinki), Johan Lassus(University of Helsinki), John Parissis(National and Kapodistrian University of Athens), Jordi Sans‐Roselló(Universitat Autònoma de Barcelona), Valentina Carubelli(Surgical Specialties (Canada)), Mercedes Rivas‐Lasarte(Universitat Autònoma de Barcelona), Marek Banaszewski(Institute of Cardiology), Oliver Hartmann
Cited by 89
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
|New England Journal of Medicine|2012|2.8k